BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $151,000 | -28.1% | 2,850 | -16.7% | 0.00% | – |
Q2 2020 | $210,000 | +82.6% | 3,421 | +68.1% | 0.00% | – |
Q1 2020 | $115,000 | -67.0% | 2,035 | -66.8% | 0.00% | – |
Q4 2019 | $349,000 | +66.2% | 6,135 | +56.2% | 0.00% | – |
Q3 2019 | $210,000 | -11.0% | 3,928 | -0.7% | 0.00% | – |
Q2 2019 | $236,000 | +84.4% | 3,955 | +92.6% | 0.00% | – |
Q1 2019 | $128,000 | +1063.6% | 2,053 | +1073.1% | 0.00% | – |
Q4 2018 | $11,000 | -91.3% | 175 | -91.9% | 0.00% | – |
Q3 2018 | $126,000 | +563.2% | 2,156 | +420.8% | 0.00% | – |
Q2 2018 | $19,000 | -63.5% | 414 | -64.9% | 0.00% | – |
Q1 2018 | $52,000 | +33.3% | 1,180 | +31.7% | 0.00% | – |
Q4 2017 | $39,000 | +550.0% | 896 | +584.0% | 0.00% | – |
Q3 2017 | $6,000 | -90.9% | 131 | -90.3% | 0.00% | – |
Q2 2017 | $66,000 | -83.1% | 1,351 | -81.0% | 0.00% | – |
Q1 2017 | $390,000 | +191.0% | 7,125 | +196.9% | 0.00% | – |
Q4 2016 | $134,000 | +6600.0% | 2,400 | +6757.1% | 0.00% | – |
Q3 2016 | $2,000 | -93.8% | 35 | -95.4% | 0.00% | – |
Q4 2015 | $32,000 | +357.1% | 761 | +345.0% | 0.00% | – |
Q3 2015 | $7,000 | -56.2% | 171 | -43.6% | 0.00% | – |
Q2 2015 | $16,000 | -64.4% | 303 | -72.9% | 0.00% | – |
Q1 2015 | $45,000 | +462.5% | 1,117 | +442.2% | 0.00% | – |
Q4 2014 | $8,000 | -70.4% | 206 | -73.9% | 0.00% | – |
Q3 2014 | $27,000 | +1250.0% | 788 | +885.0% | 0.00% | – |
Q2 2014 | $2,000 | -75.0% | 80 | -80.0% | 0.00% | – |
Q4 2013 | $8,000 | – | 401 | +40000.0% | 0.00% | – |
Q3 2013 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q2 2013 | $82,000 | – | 5,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |